Frazer Morgan

Company: Kinaset Therapeutics, Inc

Job title: Chief Development Officer & Co-Founder

Seminars:

Updates on Non-Oral JAKi Therapy: Unique Challenges & Interest 5:00 pm

Outlining current challenges and opportunities with alternative JAKi application Sharing insights from multidisciplinary backgrounds and application experience Speculating on the upcoming therapeutic landscape and potential for alternative JAKi interventionRead more

day: Day One

Developing inhaled JAKs to Address Unmet Needs in Respiratory Disease 4:35 pm

Detailing the mechanism of action for JAK inhibition in asthma Providing key challenges in inhaled JAK development Describing a KN-002 program overviewRead more

day: Day One